Skip to main content
. 2019 Oct 11;10:1135. doi: 10.3389/fphar.2019.01135

Figure 5.

Figure 5

Effect of SAL on cell viability of H9c2 cells in the absence and presence of DOX. (A) Cell viability of H9c2 cells in the absence of DOX. (B) Cell viability of H9c2 cells in the presence of DOX. * P < 0.05, ** P < 0.01 versus control group, # P < 0.05, ## P < 0.01 versus DOX group (n = 6). Results were expressed as percentages of the control group. Data are shown as mean ± SD (n = 6). SAL, salsolinol; DOX, doxorubicin.